Lexington Medical Secures Growth Investment from Ampersand Capital Partners
Summary
The partnership underscores Ampersands confidence in Lexingtons potential to redefine surgical stapling standards and positions the company for accelerated growth in product innovation, smart manufacturing, and global market expansion.Founded in 2013 and headquartered in Bedford, MA, Lexington Medical designs and manufactures high-performance endoscopic stapling devices, which are proudly made in the USA and used in a wide range of surgical procedures. With international offices in Switzerland, Australia, Germany, and the UK, and a team of approximately 150 employees, Lexington has built a patented portfolio of over 40 SKUs that are trusted by surgeons in more than 35 countries. Rooted in an engineering driven and talent-dense, collaborative culture, Lexington drives continuous innovation through U.S.-based design and manufacturing, working closely with leading surgeons to enhance patient outcomes. Learn more at www.lexington-med.com or follow us on LinkedIn.Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams.